These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 31100197)

  • 1. Purpurogallin is a novel mitogen-activated protein kinase kinase 1/2 inhibitor that suppresses esophageal squamous cell carcinoma growth in vitro and in vivo.
    Xie X; Zu X; Liu F; Wang T; Wang X; Chen H; Liu K; Wang P; Liu F; Zheng Y; Bode AM; Dong Z; Kim DJ
    Mol Carcinog; 2019 Jul; 58(7):1248-1259. PubMed ID: 31100197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scutellarin Suppresses Patient-Derived Xenograft Tumor Growth by Directly Targeting AKT in Esophageal Squamous Cell Carcinoma.
    Liu F; Zu X; Xie X; Zhang Y; Liu K; Chen H; Wang T; Bode AM; Dong Z; Kim DJ
    Cancer Prev Res (Phila); 2019 Dec; 12(12):849-860. PubMed ID: 31554627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gossypetin is a novel MKK3 and MKK6 inhibitor that suppresses esophageal cancer growth in vitro and in vivo.
    Xie X; Liu K; Liu F; Chen H; Wang X; Zu X; Ma X; Wang T; Wu Q; Zheng Y; Bode AM; Dong Z; Kim DJ
    Cancer Lett; 2019 Feb; 442():126-136. PubMed ID: 30391783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetyl-macrocalin B suppresses tumor growth in esophageal squamous cell carcinoma and exhibits synergistic anti-cancer effects with the Chk1/2 inhibitor AZD7762.
    Wang JN; Che Y; Yuan ZY; Lu ZL; Li Y; Zhang ZR; Li N; Li RD; Wan J; Sun HD; Sun N; Puno PT; He J
    Toxicol Appl Pharmacol; 2019 Feb; 365():71-83. PubMed ID: 30633885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A monomer purified from Paris polyphylla (PP-22) triggers S and G2/M phase arrest and apoptosis in human tongue squamous cell carcinoma SCC-15 by activating the p38/cdc25/cdc2 and caspase 8/caspase 3 pathways.
    Ke JY; Zhang W; Gong RS; Cen WJ; Huang HQ; Li YR; Kong WD; Jiang JW
    Tumour Biol; 2016 Nov; 37(11):14863-14872. PubMed ID: 27644244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of Rictor enhances cell sensitivity to PI3K inhibitor LY294002 by blocking mTORC2-medicated phosphorylation of Akt/PRAS40 in esophageal squamous cell carcinoma.
    Hou G; Zhao Q; Zhang M; Fan T; Liu M; Shi X; Ren Y; Wang Y; Zhou J; Lu Z
    Biomed Pharmacother; 2018 Oct; 106():1348-1356. PubMed ID: 30119206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethyl gallate as a novel ERK1/2 inhibitor suppresses patient-derived esophageal tumor growth.
    Liu F; Zu X; Xie X; Liu K; Chen H; Wang T; Liu F; Bode AM; Zheng Y; Dong Z; Kim DJ
    Mol Carcinog; 2019 Apr; 58(4):533-543. PubMed ID: 30499613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoliquiritigenin Suppressed Esophageal Squamous Carcinoma Growth by Blocking EGFR Activation and Inducing Cell Cycle Arrest.
    Ye L; Zhang J; Zhang Y; Gu B; Zhu H; Mao X
    Biomed Res Int; 2020; 2020():9259852. PubMed ID: 32190688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting p21-activated kinase 1 inhibits growth and metastasis via Raf1/MEK1/ERK signaling in esophageal squamous cell carcinoma cells.
    Chen L; Bi S; Hou J; Zhao Z; Wang C; Xie S
    Cell Commun Signal; 2019 Apr; 17(1):31. PubMed ID: 30971268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CDK4/6 inhibitor-SHR6390 exerts potent antitumor activity in esophageal squamous cell carcinoma by inhibiting phosphorylated Rb and inducing G1 cell cycle arrest.
    Wang J; Li Q; Yuan J; Wang J; Chen Z; Liu Z; Li Z; Lai Y; Gao J; Shen L
    J Transl Med; 2017 Jun; 15(1):127. PubMed ID: 28578693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dracorhodin perchlorate induces apoptosis and G2/M cell cycle arrest in human esophageal squamous cell carcinoma through inhibition of the JAK2/STAT3 and AKT/FOXO3a pathways.
    Lu Z; Lu C; Li C; Jiao Y; Li Y; Zhang G
    Mol Med Rep; 2019 Sep; 20(3):2091-2100. PubMed ID: 31322237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrochalcone Echinatin Triggers Apoptosis of Esophageal Squamous Cell Carcinoma via ROS- and ER Stress-Mediated Signaling Pathways.
    Kwak AW; Choi JS; Lee MH; Oh HN; Cho SS; Yoon G; Liu K; Chae JI; Shim JH
    Molecules; 2019 Nov; 24(22):. PubMed ID: 31717502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted therapy of the AKT kinase inhibits esophageal squamous cell carcinoma growth in vitro and in vivo.
    Liu X; Song M; Wang P; Zhao R; Chen H; Zhang M; Shi Y; Liu K; Liu F; Yang R; Li E; Bode AM; Dong Z; Lee MH
    Int J Cancer; 2019 Aug; 145(4):1007-1019. PubMed ID: 30887517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diallyl disulfide induces G2/M arrest and promotes apoptosis through the p53/p21 and MEK-ERK pathways in human esophageal squamous cell carcinoma.
    Yin X; Zhang R; Feng C; Zhang J; Liu D; Xu K; Wang X; Zhang S; Li Z; Liu X; Ma H
    Oncol Rep; 2014 Oct; 32(4):1748-56. PubMed ID: 25175641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential therapeutic effect of targeting glycogen synthase kinase 3β in esophageal squamous cell carcinoma.
    Bolidong D; Domoto T; Uehara M; Sabit H; Okumura T; Endo Y; Nakada M; Ninomiya I; Miyashita T; Wong RW; Minamoto T
    Sci Rep; 2020 Jul; 10(1):11807. PubMed ID: 32678196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corilagin Inhibits Esophageal Squamous Cell Carcinoma by Inducing DNA Damage and Down-Regulation of RNF8.
    Qiu F; Liu L; Lin Y; Yang Z; Qiu F
    Anticancer Agents Med Chem; 2019; 19(8):1021-1028. PubMed ID: 30848215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neferine induces apoptosis by modulating the ROS‑mediated JNK pathway in esophageal squamous cell carcinoma.
    An K; Zhang Y; Liu Y; Yan S; Hou Z; Cao M; Liu G; Dong C; Gao J; Liu G
    Oncol Rep; 2020 Sep; 44(3):1116-1126. PubMed ID: 32705225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rabdocoestin B exhibits antitumor activity by inducing G2/M phase arrest and apoptosis in esophageal squamous cell carcinoma.
    Wang J; Zhang Z; Che Y; Yuan Z; Lu Z; Li Y; Wan J; Sun H; Chen Z; Pu J; He J
    Cancer Chemother Pharmacol; 2018 Mar; 81(3):469-481. PubMed ID: 29308536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppressor of cytokine signaling-1 gene therapy induces potent antitumor effect in patient-derived esophageal squamous cell carcinoma xenograft mice.
    Sugase T; Takahashi T; Serada S; Nakatsuka R; Fujimoto M; Ohkawara T; Hara H; Nishigaki T; Tanaka K; Miyazaki Y; Makino T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Kishimoto T; Mori M; Doki Y; Naka T
    Int J Cancer; 2017 Jun; 140(11):2608-2621. PubMed ID: 28233302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lapachol is a novel ribosomal protein S6 kinase 2 inhibitor that suppresses growth and induces intrinsic apoptosis in esophageal squamous cell carcinoma cells.
    Zu X; Xie X; Zhang Y; Liu K; Bode AM; Dong Z; Kim DJ
    Phytother Res; 2019 Sep; 33(9):2337-2346. PubMed ID: 31225674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.